January 8, 2026 January 8, 2026Categories News StoriesWATCH: Dr. Joe Sparano discusses a new AI tool for breast cancer recurrence screening
January 4, 2026 January 4, 2026Categories News StoriesJAMA publishes ALCHEMIST EA5142 results: Nivolumab does not further reduce risk of recurrence in non-small cell lung cancer patients who completed standard post-surgery treatment
December 22, 2025 December 22, 2025Categories News StoriesWATCH: Dr. Joe Sparano talks with LinkedIn News about using AI for predicting breast cancer recurrence
November 3, 2025 November 3, 2025Categories News StoriesSTAMP (EA6174), the largest trial of adjuvant pembrolizumab in Merkel cell carcinoma, reports key benefit
October 30, 2025 October 30, 2025Categories News StoriesWATCH: Dr. Janice Mehnert discusses STAMP (EA6174) trial results; adjuvant pembrolizumab in resected Merkel cell carcinoma shows improved distant metastasis-free survival
October 13, 2025 October 13, 2025Categories News StoriesNow Enrolling: STOPGAP II trial opens for patients with stomach cancer
October 13, 2025 October 13, 2025Categories News StoriesInstitution Spotlight: Delaware/ChristianaCare NCORP
October 3, 2025 October 3, 2025Categories News StoriesBiomarker breakthroughs at ASTRO 2025 (features a discovery from the E3805 CHAARTED prostate cancer trial)
October 2, 2025 October 2, 2025Categories News StoriesDr. Xiaolei Shi on validating the APUC-6 signature in metastatic prostate cancer from the E3805 CHAARTED trial
